510(k) Report

FDA applicant

Personal Genome Diagnostics, Inc.

Baltimore, MD3 decisions2020–20260 recalls

FDA records 3 decisions for Personal Genome Diagnostics, Inc. (Baltimore, MD) from 2020 to 2026: 1 510(k) clearance, 1 De Novo grant and 1 original PMA approval. Most are in product codes PZM (Next Generation Sequencing Based Tumor…) and SBY (High Throughput Sequencing Based Tumor…). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Personal Genome Diagnostics”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, pathology panel, where it files most

How often FDA has decided Personal Genome Diagnostics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2024

2020: 12024: 12026 (partial year): 1
2020high 1 (2020) · low 0 (2021)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2020.

FIG. 1 — Personal Genome Diagnostics, Inc. by year, 2020–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Personal Genome Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Personal”

FDA records each applicant name separately; these may or may not be the same firm.